NICE will allow an appeal against its decision not to recommend Novartis’s Lucentis for diabetic macular oedema. The appeal came …
Sanofi Pasteur MSD has appointed Dr Aidrian Kilcoyne as medical director in the UK. He joins the company from Roche …
NICE has asked for more information on Pradaxa, after deciding in preliminary guidance that the drug is not cost-effective in …
Pfizer has won a US patent infringement case against generics giant Teva, stopping the company from making its own version …
Our round-up of news from the contract research sector includes the rejection of a cancer drug by the FDA because …
Of the $1.2 trillion spent globally each year on R&D across corporations and academia, 40 per cent – much the …
India’s Ipca Laboratories has bought UK chemistry services firm Onyx Scientific for around £4.6 million ($7.5m). The Mumbai-based company, a …
The pharmaceutical contract manufacturing sector looks set for a return to historical growth over the next five years, after a …
Astellas Pharma has appointed Dr Christopher Thomson as executive director of its new European Oncology Unit. Dr Thomson will …
Jubilant announces an $80 million agreement to supply an unnamed product over the next three years, plus there are facility …

GlaxoSmithKline’s new drug IPX066 has helped Parkinson’s disease patients retain their motor skills after their medication wore off. IPX066, which …

Pharma companies must adapt to a new level of engagement on Facebook after new rules from the social network forcing …
New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …
New genetic links to the immune system have been identified as a possible trigger for multiple sclerosis. The exact causes …
Indian drugmaker Ranbaxy Laboratories has decided to close down a manufacturing facility in the USA which has been under scrutiny …
GlaxoSmithKline has signed a deal to develop new tests with Enigma Diagnostics, extending a 2009 agreement with the Salisbury-based company. …
Therapeutics PLUS, a free online medical education offering to healthcare professionals has been re-launched. The online resource has been created …

Pfizer has paid out the first compensation to families of children who died during a meningitis drug trial in Nigeria. …

Skin cancer treatment Zelboraf looks set to gain FDA approval months ahead of schedule. Roche and Daiichi Sankyo’s drug is …